Jacqueline Carla Yano Maher MD, FACOG

HRC Fertility Pasadena is proud to welcome Jacqueline Maher, MD, FACOG of HRC Fertility Pasadena. to our group of award winning physicians.

Dr. Jacqueline Carla Yano Maher is a board-certified reproductive endocrinologist and infertility specialist with advanced expertise in fertility preservation and complex reproductive conditions. In October 2026, she will be joining HRC Fertility’s Pasadena team, bringing a distinguished background in both clinical care and research.

Dr. Maher earned her medical degree from Boston University School of Medicine and completed her residency in Obstetrics and Gynecology at Mount Sinai Beth Israel in New York. She then pursued fellowship training in Reproductive Endocrinology and Infertility at Johns Hopkins University. She is board certified in both Obstetrics and Gynecology and Reproductive Endocrinology and Infertility, and is a Fellow of the American College of Obstetricians and Gynecologists (FACOG).

Prior to joining HRC Fertility, Dr. Maher served as a Staff Clinician and Associate Research Physician at the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), as well as an attending physician at Children’s National Hospital. She is the Director of Female Fertility Preservation and has extensive experience caring for patients with complex medical conditions, including those requiring fertility preservation due to cancer or other health concerns.

Dr. Maher’s clinical and research interests include oncofertility, diminished ovarian reserve, premature ovarian insufficiency, and reproductive care for adolescents and young adults. She has authored numerous peer-reviewed publications, book chapters, and national presentations, and is widely recognized for her contributions to advancing fertility preservation and improving access to reproductive care.

Known for her compassionate and individualized approach, Dr. Maher is dedicated to helping patients navigate their fertility journey with confidence, offering the latest evidence-based treatments tailored to each patient’s unique needs.